FenoLogica Biosciences, Inc.

2:00 PM - 2:15 PM (EDT), Tuesday, October 22, 2019 ・ 2nd Floor
Unlocking Opportunities in the New Frontier of Synthetic Biology - FenoLogica enables microbial researchers and bioengineers to do what they haven't been able to before. Our powerful instrumentation and cloud-based software tools are specifically designed to unlock the vital link between genomics and the understanding of biologic traits and behaviors (phenotypes) in cell biology. Functional data from large, synthetically derived, gene-variant cell libraries – using dynamic multiplexed assays – lead to broader experimental inquiry, quicker discoveries, and more precise biologic signatures. This data is critical to advancing everything from genetic related diagnostics and pharmaceutical discovery, to the development of microbiome therapeutics, novel biofuels, agricultural products, food science applications and biomaterials. These techniques have promise in solving the cause and cure of disease, helping our planet’s sustainability, and advancing humankind.
Company Type:
Company Website:
Company HQ State:
Washington
Company HQ Country:
United States
Year Founded:
2016
Main Therapeutic Focus:
Lead Product in Development:
Maverick High-throughput Phenotype Classification Platform
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided